Senner Christopher J. — SEC Form 4 filings
SEC reporting owner CIK 1648367. 20 Form 4 filings on record with FilingPulse; latest filed 2026-06-15.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2024-01-16 to 2026-06-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 5 filings — 354,110 shares, $13,614,206 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: sale of 100,000 shares @ $46.00 ($4,600,000) in EXELIXIS, INC., filed 2025-05-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EXELIXIS, INC. (EXEL) | EVP and CFO | 15 | — | 6 legs · 354,110 sh · $13,614,206 | 24 |
| Quince Therapeutics, Inc. (QNCX) | Director | 5 | — | — | 5 |
Form 4 filings — Senner Christopher J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 2,700 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | EXELIXIS, INC. (EXEL) | Tax withholding (F): 40,892 @ $51.10 · Sale (S): 34,901 @ $50 | EDGAR |
| 2026-03-02 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 52,018 @ $0 | EDGAR |
| 2026-02-18 | 4 | EXELIXIS, INC. (EXEL) | Sale (S): 34,278 @ $43 · Tax withholding (F): 35,870 @ $43.92 · Sale (S): 30,617 @ $43.67 | EDGAR |
| 2026-01-21 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 21,810 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 149,474 @ $0 · Tax withholding (F): 40,459 @ $45.23 | EDGAR |
| 2025-06-06 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | EXELIXIS, INC. (EXEL) | Tax withholding (F): 41,422 @ $44.65 · Option exercise (M): 100,000 @ $18.80 · Sale (S): 100,000 @ $46 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 170,009 @ $0 | EDGAR |
| 2025-02-28 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 59,648 @ $0 | EDGAR |
| 2025-02-26 | 4 | EXELIXIS, INC. (EXEL) | Option exercise (M): 29,314 @ $18.80 · Sale (S): 29,314 @ $36.14 · Option exercise (M): 29,314 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | EXELIXIS, INC. (EXEL) | Tax withholding (F): 21,591 @ $35 | EDGAR |
| 2025-01-17 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 132,973 @ $0 · Tax withholding (F): 35,949 @ $37.27 | EDGAR |
| 2025-01-08 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 35,274 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | EXELIXIS, INC. (EXEL) | Tax withholding (F): 17,506 @ $35.05 | EDGAR |
| 2024-08-09 | 4 | EXELIXIS, INC. (EXEL) | Option exercise (M): 125,000 @ $24.41 · Sale (S): 125,000 @ $27.19 · Option exercise (M): 125,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | EXELIXIS, INC. (EXEL) | Tax withholding (F): 8,621 @ $20.99 · Tax withholding (F): 10,211 @ $20.99 · Tax withholding (F): 11,478 @ $20.99 | EDGAR |
| 2024-02-27 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 82,121 @ $0 | EDGAR |
| 2024-01-16 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 80,186 @ $0 · Tax withholding (F): 21,862 @ $22.86 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1648367 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →